Valsartan
Novartis to Appeal Court Decision on Entresto Combination Patent; Confirms 2023 Guidance and Mid-Term Outlook
SG Tylor
Source: Novartis On July 7, 2023, Novartis received a negative decision from the US District Court regarding the validity of ...
